CD8A and cancer: The same phenotype has been observed in cancer: Nrp-1 expression on CD8+ T cells was accompanied by elevated expression of CD44, CD69 and CD25, but also by several co-inhibitory molecules such as PD-1, CTLA-4, Lag-3 and Tim-3 [15, 18].